NASDAQ:AHPI

Allied Healthcare Products Competitors

$4.57
-0.06 (-1.30 %)
(As of 04/16/2021 11:01 AM ET)
Add
Compare
Today's Range
$4.38
Now: $4.57
$4.57
50-Day Range
$4.24
MA: $4.83
$5.52
52-Week Range
$4.07
Now: $4.57
$16.39
Volume175 shs
Average Volume465,417 shs
Market Capitalization$18.33 million
P/E RatioN/A
Dividend YieldN/A
Beta-5.06

Competitors

Allied Healthcare Products (NASDAQ:AHPI) Vs. ISRG, EW, ALGN, ZBH, STE, and SNN

Should you be buying AHPI stock or one of its competitors? Companies in the industry of "surgical appliances & supplies" are considered alternatives and competitors to Allied Healthcare Products, including Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), STERIS (STE), and Smith & Nephew (SNN).

Allied Healthcare Products (NASDAQ:AHPI) and Intuitive Surgical (NASDAQ:ISRG) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for Allied Healthcare Products and Intuitive Surgical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
Intuitive Surgical381102.36

Intuitive Surgical has a consensus price target of $750.9444, indicating a potential downside of 7.12%. Given Intuitive Surgical's higher probable upside, analysts plainly believe Intuitive Surgical is more favorable than Allied Healthcare Products.

Insider and Institutional Ownership

9.5% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are held by institutional investors. 23.8% of Allied Healthcare Products shares are held by insiders. Comparatively, 1.6% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Allied Healthcare Products has a beta of -5.06, meaning that its stock price is 606% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.

Profitability

This table compares Allied Healthcare Products and Intuitive Surgical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
Intuitive Surgical24.45%12.08%10.44%

Earnings and Valuation

This table compares Allied Healthcare Products and Intuitive Surgical's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
Intuitive Surgical$4.48 billion21.37$1.38 billion$9.9581.26

Intuitive Surgical has higher revenue and earnings than Allied Healthcare Products.

Summary

Intuitive Surgical beats Allied Healthcare Products on 10 of the 11 factors compared between the two stocks.

Allied Healthcare Products (NASDAQ:AHPI) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for Allied Healthcare Products and Edwards Lifesciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
Edwards Lifesciences261302.52

Edwards Lifesciences has a consensus price target of $91.1569, indicating a potential upside of 3.35%. Given Edwards Lifesciences' higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Allied Healthcare Products.

Insider and Institutional Ownership

9.5% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 80.9% of Edwards Lifesciences shares are held by institutional investors. 23.8% of Allied Healthcare Products shares are held by insiders. Comparatively, 1.5% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Allied Healthcare Products has a beta of -5.06, meaning that its stock price is 606% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Profitability

This table compares Allied Healthcare Products and Edwards Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
Edwards Lifesciences18.18%29.00%18.10%

Earnings and Valuation

This table compares Allied Healthcare Products and Edwards Lifesciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
Edwards Lifesciences$4.35 billion12.62$1.05 billion$1.8647.42

Edwards Lifesciences has higher revenue and earnings than Allied Healthcare Products.

Summary

Edwards Lifesciences beats Allied Healthcare Products on 10 of the 11 factors compared between the two stocks.

Allied Healthcare Products (NASDAQ:AHPI) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for Allied Healthcare Products and Align Technology, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
Align Technology13902.62

Align Technology has a consensus price target of $502.1667, indicating a potential downside of 16.36%. Given Align Technology's higher probable upside, analysts plainly believe Align Technology is more favorable than Allied Healthcare Products.

Insider and Institutional Ownership

9.5% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 85.8% of Align Technology shares are held by institutional investors. 23.8% of Allied Healthcare Products shares are held by insiders. Comparatively, 1.2% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Allied Healthcare Products has a beta of -5.06, meaning that its stock price is 606% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500.

Profitability

This table compares Allied Healthcare Products and Align Technology's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
Align Technology76.00%68.99%46.64%

Earnings and Valuation

This table compares Allied Healthcare Products and Align Technology's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
Align Technology$2.41 billion19.74$442.78 million$4.96121.05

Align Technology has higher revenue and earnings than Allied Healthcare Products.

Summary

Align Technology beats Allied Healthcare Products on 10 of the 11 factors compared between the two stocks.

Allied Healthcare Products (NASDAQ:AHPI) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Risk & Volatility

Allied Healthcare Products has a beta of -5.06, meaning that its stock price is 606% less volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for Allied Healthcare Products and Zimmer Biomet, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
Zimmer Biomet131632.91

Zimmer Biomet has a consensus price target of $167.8636, indicating a potential downside of 1.64%. Given Zimmer Biomet's higher probable upside, analysts plainly believe Zimmer Biomet is more favorable than Allied Healthcare Products.

Insider and Institutional Ownership

9.5% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 87.2% of Zimmer Biomet shares are held by institutional investors. 23.8% of Allied Healthcare Products shares are held by insiders. Comparatively, 0.4% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Allied Healthcare Products and Zimmer Biomet's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
Zimmer Biomet0.52%10.07%4.93%

Earnings and Valuation

This table compares Allied Healthcare Products and Zimmer Biomet's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
Zimmer Biomet$7.98 billion4.45$1.13 billion$7.8721.69

Zimmer Biomet has higher revenue and earnings than Allied Healthcare Products.

Summary

Zimmer Biomet beats Allied Healthcare Products on 11 of the 12 factors compared between the two stocks.

Allied Healthcare Products (NASDAQ:AHPI) and STERIS (NYSE:STE) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Volatility & Risk

Allied Healthcare Products has a beta of -5.06, meaning that its share price is 606% less volatile than the S&P 500. Comparatively, STERIS has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Allied Healthcare Products and STERIS, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
STERIS02302.60

STERIS has a consensus price target of $214.25, indicating a potential upside of 3.76%. Given STERIS's higher probable upside, analysts clearly believe STERIS is more favorable than Allied Healthcare Products.

Insider & Institutional Ownership

9.5% of Allied Healthcare Products shares are owned by institutional investors. Comparatively, 90.0% of STERIS shares are owned by institutional investors. 23.8% of Allied Healthcare Products shares are owned by insiders. Comparatively, 1.2% of STERIS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Allied Healthcare Products and STERIS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
STERIS13.97%14.44%9.32%

Valuation and Earnings

This table compares Allied Healthcare Products and STERIS's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
STERIS$3.03 billion5.81$407.61 million$5.6436.61

STERIS has higher revenue and earnings than Allied Healthcare Products.

Summary

STERIS beats Allied Healthcare Products on 10 of the 11 factors compared between the two stocks.

Allied Healthcare Products (NASDAQ:AHPI) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Volatility & Risk

Allied Healthcare Products has a beta of -5.06, meaning that its share price is 606% less volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Allied Healthcare Products and Smith & Nephew, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allied Healthcare Products0000N/A
Smith & Nephew24602.33

Smith & Nephew has a consensus price target of $47.1667, indicating a potential upside of 17.74%. Given Smith & Nephew's higher probable upside, analysts clearly believe Smith & Nephew is more favorable than Allied Healthcare Products.

Insider & Institutional Ownership

9.5% of Allied Healthcare Products shares are owned by institutional investors. Comparatively, 8.9% of Smith & Nephew shares are owned by institutional investors. 23.8% of Allied Healthcare Products shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Allied Healthcare Products and Smith & Nephew's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allied Healthcare Products-7.49%-27.77%-14.45%
Smith & NephewN/AN/AN/A

Valuation and Earnings

This table compares Allied Healthcare Products and Smith & Nephew's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allied Healthcare Products$31.89 million0.57$-3,010,000.00N/AN/A
Smith & Nephew$5.14 billion3.43$600 million$2.0419.64

Smith & Nephew has higher revenue and earnings than Allied Healthcare Products.

Summary

Smith & Nephew beats Allied Healthcare Products on 9 of the 11 factors compared between the two stocks.


Allied Healthcare Products Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$808.53-0.5%$95.26 billion$4.48 billion92.09Upcoming Earnings
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.4$88.20-0.2%$54.74 billion$4.35 billion70.56Upcoming Earnings
Analyst Report
Align Technology logo
ALGN
Align Technology
1.9$600.39-1.0%$47.97 billion$2.41 billion27.32Analyst Report
Zimmer Biomet logo
ZBH
Zimmer Biomet
2.1$170.67-0.6%$35.78 billion$7.98 billion1,066.75Analyst Upgrade
STERIS logo
STE
STERIS
2.1$206.49-0.1%$17.64 billion$3.03 billion41.88Analyst Downgrade
Increase in Short Interest
Smith & Nephew logo
SNN
Smith & Nephew
2.1$40.06-0.9%$17.45 billion$5.14 billion19.64Unusual Options Activity
Analyst Revision
News Coverage
MSA Safety logo
MSA
MSA Safety
2.1$153.84-0.1%$6.02 billion$1.40 billion43.58
Avanos Medical logo
AVNS
Avanos Medical
1.5$45.33-0.9%$2.20 billion$697.60 million156.31
Eargo logo
EAR
Eargo
1.0$46.91-2.2%$1.84 billionN/A0.00Increase in Short Interest
Lockup Expiration
Establishment Labs logo
ESTA
Establishment Labs
1.2$68.50-5.2%$1.70 billion$89.57 million-40.53Decrease in Short Interest
Inogen logo
INGN
Inogen
1.2$65.04-0.6%$1.46 billion$361.94 million-722.59Insider Selling
Analyst Revision
News Coverage
Sientra logo
SIEN
Sientra
1.6$6.95-1.3%$403.20 million$83.70 million-3.90Analyst Upgrade
Increase in Short Interest
Invacare logo
IVC
Invacare
1.6$8.86-0.3%$306.03 million$927.96 million-7.20Analyst Downgrade
SMTI
Sanara MedTech
0.8$29.85-0.3%$227.37 million$11.77 million-23.14Decrease in Short Interest
Gap Down
Lakeland Industries logo
LAKE
Lakeland Industries
1.6$27.26-3.8%$226.97 million$107.81 million7.74Earnings Announcement
Analyst Report
News Coverage
Gap Down
Surgalign logo
SRGA
Surgalign
1.7$1.77-4.5%$204.00 million$308.38 million-0.98Increase in Short Interest
Surgalign logo
SRGA
Surgalign
1.4$1.77-4.5%$204.00 million$308.38 million-0.98Increase in Short Interest
Conformis logo
CFMS
Conformis
1.3$0.82-1.1%$151.23 million$77.43 million-2.41Gap Up
ReWalk Robotics logo
RWLK
ReWalk Robotics
1.4$1.76-6.3%$86.19 million$4.87 million-1.40Decrease in Short Interest
CollPlant Biotechnologies logo
CLGN
CollPlant Biotechnologies
1.1$13.79-3.8%$81.14 million$2.32 million-6.90Analyst Downgrade
Decrease in Short Interest
Gap Up
Predictive Oncology logo
POAI
Predictive Oncology
1.3$1.04-8.7%$55.14 million$1.41 million-0.17
NanoVibronix logo
NAOV
NanoVibronix
0.5$0.85-0.5%$11.39 million$530,000.00-1.42Decrease in Short Interest
Gap Up
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.